In previous comprehensive phosphoproteomics analyses of NB cells treated with ALK inhibitors, we noted changes in putative ATR target sites (S/TQ motifs) on the SAD1/UNC84 domain protein-2 (SUN2), a component of the LINC complex38,39. Here, ALK is linked to neuroblastoma.